Guide to being Finnish

First Russian Pharmaceutical Company to Launch in Finland

Posted by | 12th September 2013 | Finland News

Cytomed, a Russian pharmaceutical company has recently been granted permission to built its own factory in Lappeenranta, Finland.

Cytomed will be the first Russian company to operate in Finland and has already been given permission to operate by the Finnish Medicines Agency Fimea. The company is expected to being its activity in the spring of 2014 with medicines and drugs produced in Lappeenranta to be sold and marketed primarily in Russia.


Chief Executive of Cytomed, Julia Volkova commented recently that a lot of equipment testing and process management still has to be done before operations begin.

About Cytomed

Cytomed was founded in Russia in 1989 and historically, the company has registered and produced drugs and medicines to treat influenza, respiratory diseases, hormonal imbalance, prostate illnesses and a wide range of immunity-deficient conditions.

Jobs at Cytomed

Although operations haven’t yet begun and the recruitment process hasn’t either been cleary defined and put in place, Cytomed are currently running a programme according to which professionals in this industry can submit an application to register their interest so they would be considered first when the actual jobs are ready to be advertised.

You can register your interest and submity your CV by clicking here.

An email window will open and you should be able to attach your Resume. Please write a short cover letter expressing interest and title your email with some relevant details, such as “Candidate interest for Lappeenranta plant jobs“.

Related Jobs in Finland

1872 total views, 1 today

Tags: , , ,

  • vgizzo

    The provided email, does not appear to be valid. My emails are undeliverable to this address….

    • admin

      Very strange indeed, thank you for flagging it up. We’ll need to double check and we’ll get back to you.

    • admin

      Apologies about the issue with the email address provided. We had one which apparently no longer works. In the meantime, we have updated the post with a new email address which should be fine for the interim.